AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/118
INTRALABORATORY TIMELINESS OF SURGICAL PATHOLOGY REPORTS - RESULTS OF2 COLLEGE-OF-AMERICAN-PATHOLOGISTS Q-PROBES STUDIES OF BIOPSIES AND COMPLEX SPECIMENS
Authors: ZARBO RJ GEPHARDT GN HOWANITZ PJ
Citation: Rj. Zarbo et al., INTRALABORATORY TIMELINESS OF SURGICAL PATHOLOGY REPORTS - RESULTS OF2 COLLEGE-OF-AMERICAN-PATHOLOGISTS Q-PROBES STUDIES OF BIOPSIES AND COMPLEX SPECIMENS, Archives of pathology and laboratory medicine, 120(3), 1996, pp. 234-244
INTERINSTITUTIONAL COMPARISON OF FROZEN-SECTION CONSULTATION IN SMALLHOSPITALS - A COLLEGE-OF-AMERICAN-PATHOLOGISTS Q-PROBES STUDY OF 18532 FROZEN-SECTION CONSULTATION DIAGNOSES IN 233 SMALL HOSPITALS
Authors: NOVIS DA GEPHARDT GN ZARBO RJ
Citation: Da. Novis et al., INTERINSTITUTIONAL COMPARISON OF FROZEN-SECTION CONSULTATION IN SMALLHOSPITALS - A COLLEGE-OF-AMERICAN-PATHOLOGISTS Q-PROBES STUDY OF 18532 FROZEN-SECTION CONSULTATION DIAGNOSES IN 233 SMALL HOSPITALS, Archives of pathology and laboratory medicine, 120(12), 1996, pp. 1087-1093
QUALITY ASSURANCE OF AUTOPSY FACE SHEET REPORTING, FINAL AUTOPSY REPORT TURNAROUND TIME, AND AUTOPSY RATES - A COLLEGE-OF-AMERICAN-PATHOLOGISTS Q-PROBES STUDY OF 10,003 AUTOPSIES FROM 418 INSTITUTIONS
Authors: BAKER PB ZARBO RJ HOWANITZ PJ
Citation: Pb. Baker et al., QUALITY ASSURANCE OF AUTOPSY FACE SHEET REPORTING, FINAL AUTOPSY REPORT TURNAROUND TIME, AND AUTOPSY RATES - A COLLEGE-OF-AMERICAN-PATHOLOGISTS Q-PROBES STUDY OF 10,003 AUTOPSIES FROM 418 INSTITUTIONS, Archives of pathology and laboratory medicine, 120(11), 1996, pp. 1003-1008
EXTRANEOUS TISSUE IN SURGICAL PATHOLOGY - A COLLEGE-OF-AMERICAN-PATHOLOGISTS Q-PROBES STUDY OF 275 LABORATORIES
Authors: GEPHARDT GN ZARBO RJ
Citation: Gn. Gephardt et Rj. Zarbo, EXTRANEOUS TISSUE IN SURGICAL PATHOLOGY - A COLLEGE-OF-AMERICAN-PATHOLOGISTS Q-PROBES STUDY OF 275 LABORATORIES, Archives of pathology and laboratory medicine, 120(11), 1996, pp. 1009-1014
INDICATIONS AND IMMEDIATE PATIENT OUTCOMES OF PATHOLOGY INTRAOPERATIVE CONSULTATIONS - A COLLEGE-OF-AMERICAN-PATHOLOGISTS CENTERS-FOR-DISEASE-CONTROL AND PREVENTION OUTCOMES WORKING GROUP-STUDY
Authors: ZARBO RJ SCHMIDT WA BACHNER P HOWANITZ PJ MEIER FA SCHIFMAN RB BOONE DJ HERRON RM
Citation: Rj. Zarbo et al., INDICATIONS AND IMMEDIATE PATIENT OUTCOMES OF PATHOLOGY INTRAOPERATIVE CONSULTATIONS - A COLLEGE-OF-AMERICAN-PATHOLOGISTS CENTERS-FOR-DISEASE-CONTROL AND PREVENTION OUTCOMES WORKING GROUP-STUDY, Archives of pathology and laboratory medicine, 120(1), 1996, pp. 19-25
QUALITY ASSESSMENT IN ANATOMIC PATHOLOGY IN THE COST-CONSCIOUS ERA
Authors: ZARBO RJ
Citation: Rj. Zarbo, QUALITY ASSESSMENT IN ANATOMIC PATHOLOGY IN THE COST-CONSCIOUS ERA, American journal of clinical pathology, 106(4), 1996, pp. 3-10
THE EFFECT OF NUMBER OF HISTOGRAM EVENTS ON REPRODUCIBILITY AND VARIATION OF FLOW CYTOMETRIC PROLIFERATION MEASUREMENT
Authors: BROWN RD LINDEN MD MACKOWIAK P KUBUS JJ ZARBO RJ RABINOVITCH PS
Citation: Rd. Brown et al., THE EFFECT OF NUMBER OF HISTOGRAM EVENTS ON REPRODUCIBILITY AND VARIATION OF FLOW CYTOMETRIC PROLIFERATION MEASUREMENT, American journal of clinical pathology, 105(6), 1996, pp. 696-704
EVALUATION OF ANTI-P53 ANTIBODY STAINING IMMUNOREACTIVITY IN BENIGN-TUMORS AND NONNEOPLASTIC TISSUES
Authors: LINDEN MD NATHANSON SD ZARBO RJ
Citation: Md. Linden et al., EVALUATION OF ANTI-P53 ANTIBODY STAINING IMMUNOREACTIVITY IN BENIGN-TUMORS AND NONNEOPLASTIC TISSUES, Applied immunohistochemistry, 3(4), 1995, pp. 232-238
PROLIFERATION MARKERS MIB-1 AND PCNA IN PULMONARY NEUROENDOCRINE TUMORS
Authors: DURHAM JR NAKHLEH RE SWANSON PE FISCHER JR ZARBO RJ
Citation: Jr. Durham et al., PROLIFERATION MARKERS MIB-1 AND PCNA IN PULMONARY NEUROENDOCRINE TUMORS, Applied immunohistochemistry, 3(3), 1995, pp. 174-183
COORDINATE EXPRESSION OF CYTOKERATIN-7 AND CYTOKERATIN-20 DEFINES UNIQUE SUBSETS OF CARCINOMAS
Authors: WANG NP ZEE S ZARBO RJ BACCHI CE GOWN AM
Citation: Np. Wang et al., COORDINATE EXPRESSION OF CYTOKERATIN-7 AND CYTOKERATIN-20 DEFINES UNIQUE SUBSETS OF CARCINOMAS, Applied immunohistochemistry, 3(2), 1995, pp. 99-107
DO GLIOMA-CELLS EXPRESS CYTOKERATIN
Authors: BACCHI CE ZARBO RJ JIANG JJ GOWN AM
Citation: Ce. Bacchi et al., DO GLIOMA-CELLS EXPRESS CYTOKERATIN, Applied immunohistochemistry, 3(1), 1995, pp. 45-53
P53 PROTEIN EXPRESSION IN SEQUENTIAL BIOPSIES OF ORAL DYSPLASIAS AND IN-SITU CARCINOMAS
Authors: REGEZI JA ZARBO RJ REGEV E PISANTY S SILVERMAN S GAZIT D
Citation: Ja. Regezi et al., P53 PROTEIN EXPRESSION IN SEQUENTIAL BIOPSIES OF ORAL DYSPLASIAS AND IN-SITU CARCINOMAS, Journal of oral pathology & medicine, 24(1), 1995, pp. 18-22
P53 AND MDM-2 EXPRESSION IN MALIGNANT-MELANOMA - AN IMMUNOCYTOCHEMICAL STUDY OF EXPRESSION OF P53, MDM-2, AND MARKERS OF CELL-PROLIFERATIONIN PRIMARY VERSUS METASTATIC TUMORS
Authors: GELSLEICHTER L GOWN AM ZARBO RJ WANG E COLTRERA MD
Citation: L. Gelsleichter et al., P53 AND MDM-2 EXPRESSION IN MALIGNANT-MELANOMA - AN IMMUNOCYTOCHEMICAL STUDY OF EXPRESSION OF P53, MDM-2, AND MARKERS OF CELL-PROLIFERATIONIN PRIMARY VERSUS METASTATIC TUMORS, Modern pathology, 8(5), 1995, pp. 530-535
MEDULLARY CARCINOMA OF THE BREAST - INTEROBSERVER VARIABILITY IN HISTOPATHOLOGIC DIAGNOSIS
Authors: GAFFEY MJ MILLS SE FRIERSON HF ZARBO RJ BOYD JC SIMPSON JF WEISS LM
Citation: Mj. Gaffey et al., MEDULLARY CARCINOMA OF THE BREAST - INTEROBSERVER VARIABILITY IN HISTOPATHOLOGIC DIAGNOSIS, Modern pathology, 8(1), 1995, pp. 31-38
COMMON CLONAL ORIGIN OF SYNCHRONOUS PRIMARY HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - ANALYSIS BY TUMOR KARYOTYPES AND FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: WORSHAM MJ WOLMAN SR CAREY TE ZARBO RJ BENNINGER MS VANDYKE DL
Citation: Mj. Worsham et al., COMMON CLONAL ORIGIN OF SYNCHRONOUS PRIMARY HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - ANALYSIS BY TUMOR KARYOTYPES AND FLUORESCENCE IN-SITU HYBRIDIZATION, Human pathology, 26(3), 1995, pp. 251-261
IMMUNOPHENOTYPIC CHARACTERIZATION OF CELL-TYPES IN KAPOSIS-SARCOMA (KS) - CORRELATION WITH MORPHOLOGIC TUMOR STAGE
Authors: GOTTFRIED LJ LEE MW AMIN MB LINDEN MD KEOHANE ME ZARBO RJ
Citation: Lj. Gottfried et al., IMMUNOPHENOTYPIC CHARACTERIZATION OF CELL-TYPES IN KAPOSIS-SARCOMA (KS) - CORRELATION WITH MORPHOLOGIC TUMOR STAGE, Laboratory investigation, 72(1), 1995, pp. 6-6
IMMUNOHISTOCHEMICAL ASSESSMENT OF TUMOR PROLIFERATIVE ACTIVITY (MIB-1) AND P53 TUMOR-SUPPRESSOR GENE MUTATION IN HIGH-GRADE SOFT-TISSUE SARCOMAS (HGSTS) - USEFULNESS IN PREDICTING POSTTREATMENT TUMOR RESPONSE
Authors: RANDOLPH T KEOHANE ME LINDEN MD NATHANSON SD ZARBO RJ
Citation: T. Randolph et al., IMMUNOHISTOCHEMICAL ASSESSMENT OF TUMOR PROLIFERATIVE ACTIVITY (MIB-1) AND P53 TUMOR-SUPPRESSOR GENE MUTATION IN HIGH-GRADE SOFT-TISSUE SARCOMAS (HGSTS) - USEFULNESS IN PREDICTING POSTTREATMENT TUMOR RESPONSE, Laboratory investigation, 72(1), 1995, pp. 10-10
MALE BREAST-CARCINOMA - PROGNOSTIC FACTORS IN 30 CASES
Authors: RAJU U GAFFEY MJ ZARBO RJ
Citation: U. Raju et al., MALE BREAST-CARCINOMA - PROGNOSTIC FACTORS IN 30 CASES, Laboratory investigation, 72(1), 1995, pp. 23-23
PROSPECTIVE FLOW CYTOMETRIC ANALYSIS OF PLOIDY IN 211 COLORECTAL CARCINOMAS - 3-7-YEAR FOLLOW-UP AND CORRELATION AND HISTOPATHOLOGIC PARAMETERS
Authors: NAKHLEH RE ZARBO RJ MA CK BROWN R KUBUS J RABINOVITCH PS
Citation: Re. Nakhleh et al., PROSPECTIVE FLOW CYTOMETRIC ANALYSIS OF PLOIDY IN 211 COLORECTAL CARCINOMAS - 3-7-YEAR FOLLOW-UP AND CORRELATION AND HISTOPATHOLOGIC PARAMETERS, Laboratory investigation, 72(1), 1995, pp. 66-66
THE DIAGNOSTIC UTILITY OF CYTOKERATIN 2O IN THE DISCRIMINATION OF PRIMARY PULMONARY ADENOCARCINOMA FROM COLONIC ADENOCARCINOMA METASTATIC TO THE LUNG
Authors: SAVERA AT TORRES FX GOWN AM ZARBO RJ
Citation: At. Savera et al., THE DIAGNOSTIC UTILITY OF CYTOKERATIN 2O IN THE DISCRIMINATION OF PRIMARY PULMONARY ADENOCARCINOMA FROM COLONIC ADENOCARCINOMA METASTATIC TO THE LUNG, Laboratory investigation, 72(1), 1995, pp. 68-68
PROGNOSTIC-SIGNIFICANCE OF FLOW-CYTOMETRY (FCM) SYNTHETIC PHASE FRACTION (SPF) IN 168 CYTOKERATIN (CK) STAINED COLORECTAL CARCINOMAS
Authors: ZARBO RJ NAKHLEH RN BROWN R KUBUS J MA CK RABINOVITCH PS
Citation: Rj. Zarbo et al., PROGNOSTIC-SIGNIFICANCE OF FLOW-CYTOMETRY (FCM) SYNTHETIC PHASE FRACTION (SPF) IN 168 CYTOKERATIN (CK) STAINED COLORECTAL CARCINOMAS, Laboratory investigation, 72(1), 1995, pp. 71-71
ROLE OF RETINOBLASTOMA (RB) SUPPRESSOR GENE PROTEIN IN SUPERFICIAL UROTHELIAL NEOPLASIA
Authors: AMIN MB XU HJ MOHSIN SK SCHULTZ DS HU SX ZARBO RJ BENEDICT WF
Citation: Mb. Amin et al., ROLE OF RETINOBLASTOMA (RB) SUPPRESSOR GENE PROTEIN IN SUPERFICIAL UROTHELIAL NEOPLASIA, Laboratory investigation, 72(1), 1995, pp. 72-72
HAM56 IMMUNOREACTIVITY IN PSEUDOMYXOMA PERITONEIL - A POTENTIAL METHOD OF SEPARATING OVARIAN FROM APPENDICEAL PRIMARY LESIONS
Authors: DEYOUNG BR GAFFEY MJ ZARBO RJ SWANSON PE MILLS SE
Citation: Br. Deyoung et al., HAM56 IMMUNOREACTIVITY IN PSEUDOMYXOMA PERITONEIL - A POTENTIAL METHOD OF SEPARATING OVARIAN FROM APPENDICEAL PRIMARY LESIONS, Laboratory investigation, 72(1), 1995, pp. 88-88
COMPARATIVE IMMUNOPHENOTYPES OF PRIMARY CARCINOMAS OF THE KIDNEY, ADRENAL, AND LIVER - AN IMMUNOHISTOCHEMICAL STUDY WITH A PANEL OF ANTIBODIES TO INDIVIDUAL CYTOKERATINS (CKS) AND OTHER ANTIGENS
Authors: MA CK AMIN MB LINDEN RJ ZARBO RJ SAVERA AT WANG NP GOWN AM
Citation: Ck. Ma et al., COMPARATIVE IMMUNOPHENOTYPES OF PRIMARY CARCINOMAS OF THE KIDNEY, ADRENAL, AND LIVER - AN IMMUNOHISTOCHEMICAL STUDY WITH A PANEL OF ANTIBODIES TO INDIVIDUAL CYTOKERATINS (CKS) AND OTHER ANTIGENS, Laboratory investigation, 72(1), 1995, pp. 132-132
CYTOKERATIN (CK)-7 AND CK-20 IMMUNOPHENOTYPING CAN DISTINGUISH AMONG CARCINOMAS OF DIFFERENT PRIMARY SITES - AN IMMUNOHISTOCHEMICAL STUDY
Authors: ZEE S WANG NP BACCHI CE ZARBO RJ GOWN AM
Citation: S. Zee et al., CYTOKERATIN (CK)-7 AND CK-20 IMMUNOPHENOTYPING CAN DISTINGUISH AMONG CARCINOMAS OF DIFFERENT PRIMARY SITES - AN IMMUNOHISTOCHEMICAL STUDY, Laboratory investigation, 72(1), 1995, pp. 142-142
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>